Word

TT T-THERAPEUTICS

Status

Pending

Status Code

641

Status Date

Wednesday, July 10, 2024

Serial Number

98081051

Mark Type

3

Filing Date

Wednesday, July 12, 2023

Trademark Owner History

T-Therapeutics Limited

Classifications

9 Downloadable computer software for use in collecting, analyzing and organizing data in the field of pharmaceuticals, biopharmaceutical drug development and genome engineering; downloadable computer software for use in collecting, analyzing and organizing data in the field of scientific and pharmaceutical research and development; downloadable software for scientific modelling of pharmaceuticals in the field of scientific and pharmaceutical research and development; downloadable software for pharmaceutical modelling; downloadable software for research and development in the nature of collecting, analyzing and organizing data in the field of antibodies; devices for analyzing genome information, namely, laboratory devices for detecting genetic sequences; downloadable software for performing gene sequencing research and visualization; downloadable software for the managing, analysis, and visualization of biological data

5 Pharmaceutical preparations for protection and prevention from infections, cancer, disease or inflammation; pharmaceutical preparations, in particular, chemical and biological preparations for medical purposes, namely, for protection and prevention from infections, cancer, disease or inflammation; chemical preparations for use in DNA analysis for medical purposes; DNA synthesis inhibitors for medical purposes, namely, pharmaceutical preparations for protection and prevention from infections, cancer, disease or inflammation; biological preparations for the treatment of cancer; biological preparations for the treatment of viral infections; biological preparations for the treatment of autoimmune diseases; biological preparations for medical use for the treatment of infections, cancer, disease or inflammation; immunotherapeutic drugs namely, pharmaceutical preparations for protection and prevention from infections, cancer, disease or inflammation; reagents for medical use; diagnostic preparations for medical use; diagnostic reagents for medical use; preparations for detecting genetic predispositions for medical purposes

44 Medical services; diagnostic and prognostic medical services; veterinary services; medical analysis services relating to the treatment of persons; pharmaceutical advice; medical and health care services relating to DNA, genetics, and genetic pathogen testing for diagnostic or treatment purposes; medical screening and assaying in the nature of medical laboratory analysis services relating to the treatment of persons; DNA screening for medical purposes; DNA analysis services in the field of DNA sequencing for diagnostic and treatment purposes provided by medical laboratories

42 Scientific and technological services, namely, scientific research and development in the field of pharmaceuticals for genome engineering and biopharmaceutical drug development for protection from infections, cancer, disease or inflammation; technical research in the field of pharmaceutical studies; design and development of computer hardware and software; platform as a service (PAAS) featuring computer software platforms for use in database management in the field of pharmaceuticals, biopharmaceutical drug development and genome engineering; platform as a service (PAAS) featuring DNA analysis software; software as a service (SAAS) services featuring software for use in database management in the field of pharmaceuticals, biopharmaceutical drug development and genome engineering; software as a service (SAAS) featuring DNA analysis software; provision of online non-downloadable software for the management, visualization and analysis of biological data for the purposes of biomolecular research and the design and engineering of biomolecular products; DNA analysis services in the field of DNA sequencing for scientific research; provision of a web hosting platform for the analysis of DNA sequencing data for scientific research purposes and diagnostic and treatment purposes

The mark consists of an abstract design in the color light blue, within which is a white upside down letter T on top of a white right side up letter T, next to which is the word element T-THERAPEUTICS, the T and hyphen being light blue, and the word THERAPEUTICS in dark blue.
The color(s) light blue, dark blue and white is/are claimed as a feature of the mark.

Trademark Events

Jul 15, 2023

New Application Entered

Aug 10, 2023

New Application Office Supplied Data Entered

Aug 11, 2023

Notice Of Design Search Code E-Mailed

Mar 20, 2024

Assigned To Examiner

Mar 27, 2024

Teas Change Of Correspondence Received

Mar 27, 2024

Teas Change Of Owner Address Received

Mar 27, 2024

Applicant/Correspondence Changes (Non-Responsive) Entered

May 31, 2024

Teas Change Of Correspondence Received

Mar 27, 2024

Non-Final Action Written

Mar 27, 2024

Correspondence E-Mailed

May 31, 2024

Teas Change Of Owner Address Received

May 31, 2024

Applicant/Correspondence Changes (Non-Responsive) Entered

Jun 11, 2024

Correspondence Received In Law Office

Jun 11, 2024

Teas/Email Correspondence Entered

Jun 11, 2024

Teas Response To Office Action Received

Jul 10, 2024

Non-Final Action E-Mailed

Jul 10, 2024

Non-Final Action Written

Jul 10, 2024

Notification Of Non-Final Action E-Mailed